Precision chemotherapy duration in advanced ovarian cancer: neoadjuvant cycle optimization and differential treatment adaptation by cytoreduction outcome. Am J Cancer Res. 2026 Mar 15;16(3):853-865. doi: 10.62347/KESA6873. PMID: 42004056; PMCID: PMC13090502. Lin WT, Wu CH, Lin H, Ou YC, Fu HC, Tsai CC, Wang YW, Huang SW, Chen YY.